Literature DB >> 21029098

Population characteristics and survival in 127 referred cats with hypertrophic cardiomyopathy (1997 to 2005).

J Payne1, V Luis Fuentes, A Boswood, D Connolly, H Koffas, D Brodbelt.   

Abstract

OBJECTIVES: To evaluate the characteristics and survival of a recent population of cats with hypertrophic cardiomyopathy.
METHODS: Records at the Royal Veterinary College Queen Mother Hospital for Animals were searched for cats diagnosed with hypertrophic cardiomyopathy between 1997 and 2005. Referring veterinarians and owners were contacted to determine survival times.
RESULTS: Cats with hypertrophic cardiomyopathy were evaluated for population characteristics (n=127) and survival times (n=109). Overall median survival from date of hypertrophic cardiomyopathy diagnosis at the Queen Mother Hospital for Animals was 1276 days. Cats with hypertrophic cardiomyopathy were younger (P=0·009), and more likely to be male (P<0·001) compared to a hospital control group (n=1473), and Ragdolls were over-represented (P<0·05). Characteristics associated with increased survival in univariate analysis included younger age (P=0·007), asymptomatic status (P<0·001), normal left atrial size (P<0·001) and presence of systolic anterior motion of the mitral valve (P=0·003). Systolic anterior motion was associated with asymptomatic status, and did not influence survival in asymptomatic cats or those in congestive heart failure. Age, left atrial size and breed were significantly associated with survival time in a multivariate analysis. CLINICAL SIGNIFICANCE: Cats with hypertrophic cardiomyopathy and left atrial enlargement have a poorer prognosis. The positive influence of systolic anterior motion on survival is likely to be linked to its association with asymptomatic status.
© 2010 British Small Animal Veterinary Association.

Entities:  

Mesh:

Year:  2010        PMID: 21029098     DOI: 10.1111/j.1748-5827.2010.00989.x

Source DB:  PubMed          Journal:  J Small Anim Pract        ISSN: 0022-4510            Impact factor:   1.522


  35 in total

1.  Pharmacodynamic effects of ivabradine, a negative chronotropic agent, in healthy cats.

Authors:  Richard E Cober; Karsten E Schober; Tony C A Buffington; Xiaobai Li; Sabine C Riesen; John D Bonagura
Journal:  J Vet Cardiol       Date:  2011-10-24       Impact factor: 1.701

Review 2.  Inherited cardiomyopathies in veterinary medicine.

Authors:  Joshua A Stern; Yu Ueda
Journal:  Pflugers Arch       Date:  2018-10-03       Impact factor: 3.657

3.  The A31P missense mutation in cardiac myosin binding protein C alters protein structure but does not cause haploinsufficiency.

Authors:  Sabine J van Dijk; Kristina Bezold Kooiker; Stacy Mazzalupo; Yuanzhang Yang; Alla S Kostyukova; Debbie J Mustacich; Elaine R Hoye; Joshua A Stern; Mark D Kittleson; Samantha P Harris
Journal:  Arch Biochem Biophys       Date:  2016-01-09       Impact factor: 4.013

4.  Immunohistological Evaluation of Von Willebrand Factor in the Left Atrial Endocardium and Atrial Thrombi from Cats with Cardiomyopathy.

Authors:  Wan-Ching Cheng; Lois Wilkie; Tsumugi Anne Kurosawa; Melanie Dobromylskyj; Simon Lawrence Priestnall; Virginia Luis Fuentes; David J Connolly
Journal:  Animals (Basel)       Date:  2021-04-26       Impact factor: 2.752

5.  Relationship of body size to metabolic markers and left ventricular hypertrophy in cats.

Authors:  L M Freeman; J E Rush; A Feugier; I van Hoek
Journal:  J Vet Intern Med       Date:  2014-11-20       Impact factor: 3.333

6.  Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy.

Authors:  K Borgeat; K Sherwood; J R Payne; V Luis Fuentes; D J Connolly
Journal:  J Vet Intern Med       Date:  2014-10-15       Impact factor: 3.333

7.  Transient Myocardial Thickening in Cats Associated with Heart Failure.

Authors:  J Novo Matos; N Pereira; T Glaus; L Wilkie; K Borgeat; J Loureiro; J Silva; V Law; A Kranjc; D J Connolly; V Luis Fuentes
Journal:  J Vet Intern Med       Date:  2017-12-15       Impact factor: 3.333

8.  Acute effects of ivabradine on dynamic obstruction of the left ventricular outflow tract in cats with preclinical hypertrophic cardiomyopathy.

Authors:  K A Blass; K E Schober; X Li; B A Scansen; J D Bonagura
Journal:  J Vet Intern Med       Date:  2014-03-05       Impact factor: 3.333

9.  Arterial thromboembolism in 250 cats in general practice: 2004-2012.

Authors:  K Borgeat; J Wright; O Garrod; J R Payne; V L Fuentes
Journal:  J Vet Intern Med       Date:  2013-11-15       Impact factor: 3.333

10.  Concurrent diseases and conditions in cats with renal infarcts.

Authors:  M C Hickey; K Jandrey; K S Farrell; D Carlson-Bremer
Journal:  J Vet Intern Med       Date:  2014-02-16       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.